Posts tagged “N.C. Biotech Center”

5:12 a.m. today

WRAL TechWire wants to hear from you - Send WTW your news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

March 24

Humacyte's bioengineered blood vessel receives special FDA review designation

​Humacyte, a Research Triangle Park-based biotechnology company focused on regenerative medicine, has won one of the first Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration.

Sample of a Humacyl vessel Sample of a Humacyl vessel

March 23

RTP's UVision 360 looking for votes in startup showdown

UVision 360 Led by CEO Allison London Brown, UVision is focused on the development of a gynecological tool that will change the way the doctors view and operate in the endometrial cavity.

March 22

More positive lung cancer treatment data boost Heat Bio

Heat Biologics Heat Biologics reports early positive results in a Phase 2 trial of its immunotherapy lung cancer treatment.

Updated March 21

Biotech Center's Landing Pad: A welcoming place for execs planning NC operations

The Landing Pad, a program of the North Carolina Biotechnology Center, helps nascent bioscience companies to get started here or more mature companies from elsewhere in the nation or world to establish a new presence here.

N.C. Biotech Center's tower N.C. Biotech Center's tower

March 20

WTW wants to hear from you - Send WTW your news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

March 17

Qualyst Transporter Systems finds success with assays testing potential effects of drugs, cosmetics and foods on the liver

​Durham-based Qualyst Transporter Systems launched its latest assay this month, a novel in vitro way to test compounds for their potential to cause a serious liver problem called cholestiatic drug induced liver injury.

Qualyst technology Qualyst technology

March 13

Heat Bio reports positive results from early cancer drug trial

Heat Biologics Heat Biologics, a Durham company developing immunotherapies to fight cancer, has reported positive results from a Phase 1b trial of its combination treatment for non-small cell lung cancer.

March 13

Immunology synergy drives Heat Bio's acquisition play

Early this month, Heat Biologics acquired an 80 percent controlling interest in Pelican Therapeutics. The company says combining its technology with Pelican's and possibly other immunotherapies provides a synergistic treatment expected to be more effective than those used alone.

Jeff Wolf Jeff Wolf

March 13

Speak up: We want to hear from you - Send WTW your news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

March 7

Durham's Tryton Medical wins FDA approval for coronary stents

Durham-based medical device developer Tryton Medical has received U.S. Food and Drug Administration approval to market the company's Tryton Side Branch Stent for the treatment of coronary bifurcation lesions.

Tryton image of stent technology Tryton image of stent technology

Updated March 7

Duke executive: Healthcare costs can be reduced

Healthcare reform Duke's Dr. Mark McClellan stresses to CED Life Science Conference the themes of sustainable healthcare reforms for better outcomes, value-based payment in healthcare and the need for better real-world evidence of treatment success.

March 6

We want to hear from you - Send WTW your news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

March 2

Looking for investors? Corporate VCs offer some advice

Venture Capital     So, if you are an innovative startup seeking investors, how do you grab the attention of corporate venture capital funds? At the CED Life Science Conference, four corporate VCs explain how to "Follow the Money."

March 2

Premium Lock NCBIO seeks full funding for job training programs

Sam Taylor, NCBIO president, says that over the next two years, hNorth Carolina biotech manufacturers will need about 2,000 additional workers. Lobbying for full funding of North Carolina State University's biotech training program is thus a priority for NCBIO in 2017.

NCBIO President Sam Taylor NCBIO President Sam Taylor

March 2

Premium Lock Art Pappas: Receiving CED Life Science Leadership award 'humbling'

It was a big week for Art Pappas, managing partner of Pappas Ventures. He accepted the 2017 Life Science Leadership Award at the CED's Life Science Conference and CoLucid, a company his firm backed and he led as founding CEO closed its $960 million acquisition by Eli Lilly and Co. the same day.

Arthur Pappas Arthur Pappas

Updated March 1

Report: NC's life science sector drives double-digit job growth

New data shows that North Carolina's life science ecosystem continues to flourish with companies across the state increasing employment by 11 percent since 2010. But even more impressive is the industry's impact on related employment with jobs tied to life science surging by 15 percent. After a dip in 2014, related jobs surged by 31,000 in 2016.

Charting NC life science growth Charting NC life science growth

Updated February 28

Premium Lock Commerce Secretary: Life science industry helping create NC's future

Biotech   "North Carolina is one of the best places in the world for life sciences and a rich place to invest because of our universities and our talent," Anthony Copeland tells the CED Life Science Conference in Raleigh. "It's one of the few states where a product can go from lab to manufacturing. Time and again, people find inspiration in NC."

February 28

Pfizer commits $4M to NC Biotechnology Center gene therapy fellowship program

Pfizer The new program, to be managed by NCBiotech, will support distinguished postdoctoral fellowships in North Carolina university research laboratories providing advanced scientific training in gene therapy-related research.

February 27

WTW wants to hear from you - Send us news, views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith